Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous MSCs for Erectile Dysfunction in Diabetics
NCT02945462Phase 1Completed
- Sponsor
- University of Jordan
- Start
- Sep 2013
- Primary completion
- Nov 2015
- Modality
- Stem Cell Therapies
01
Overview
Phase 1, open-label, single-arm trial of autologous bone marrow derived mesenchymal stromal cells in erectile dysfunction (ED), sponsored by University of Jordan. Primary endpoint: Incidence of Treatment-Emergent Adverse Events at 6 months. Started Sep 2013; status: completed.
02
Drugs
autologous bone marrow derived mesenchymal stromal cells
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT02945462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02945462.